Analgesic interaction between butorphanol and sufentanil
	    		
		   		
		   			
		   		
	    	
    	 
    	10.3760/cma.j.issn.0254-1416.2017.08.020
   		
        
        	
        		- VernacularTitle:布托啡诺与舒芬太尼镇痛效应的相互作用
 
        	
        	
        	
        		- Author:
	        		
		        		
		        		
			        		Yingjie CHEN
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Shaoqiang HUANG
			        		
			        		
		        		
		        		
		        		
		        		
		        			
			        		
			        		Author Information
			        		
		        		
		        		
			        		
			        		
			        			1. 复旦大学附属妇产科医院麻醉科
			        		
		        		
	        		
        		 
        	
        	
        	
        	
        		- Keywords:
        			
	        			
	        				
	        				
			        		
				        		Butorphanol;
			        		
			        		
			        		
				        		Sufentanil;
			        		
			        		
			        		
				        		Drug interactions
			        		
			        		
	        			
        			
        		
 
        	
            
            
            	- From:
	            		
	            			Chinese Journal of Anesthesiology
	            		
	            		 2017;37(8):975-978
	            	
            	
 
            
            
            	- CountryChina
 
            
            
            	- Language:Chinese
 
            
            
            	- 
		        	Abstract:
			       	
			       		
				        
				        	Objective To evaluate the analgesic interaction between butorphanol and sufentanil.Methods Ninety patients,aged 18-64 yr,with body mass index <30 kg/m2,of American Society of Anesthesiologists physical status Ⅰ or Ⅱ,undergoing elective laparoscopic gynecological surgery,were divided into 3 groups (n =30 each) using a random number table:butorphanol group (group B),sufentanil group (group S) and butorphanol mixed with sufentanil group (group BS1).The doses of butorphanol and sufentanil were determined by the modified Dixon's up-and-down method.In B and S groups,the initial doses of butorphanol and sufentanil were 0.5 mg and 5 μg,respectively,with 0.1 mg and 1 μg increment/decrement,respectively.In group BS1,butorphanol combined with sufentanil at the ratio of 2 ∶ 1 based on the equivalent dose,and the initial dose was butorphanol 0.25 mg plus sufentanil 2.5 μg with 0.05 mg and 0.5 μg increment/decrement for butorphanol and sufentanil,respectively.Effective analgesia was defined as numeric rating scale pain score ≤ 3 or the extent of decrease in numeric rating scale scores > 50% within 15 min after administration.The median effective dose (ED50) and 95% confidence interval (CI) of butorphanol and sufentanil were calculated by probit analysis.Isobolographic analysis was used to analyze the analgesic interaction between butorphanol and sufentanil.When the equivalent dose of two drugs was very different from that selected in group BS1 on the basis of the actually calculated ED50 in B and S groups,the combination of butorphanol and sufentanil in group BS2 (n=30) was set at the ratio of 1 ∶ 1 based on the actual equivalent dose:the initial dose was butorphanol 0.4 mg plus sufentanil 1.8 μg with 0.1 mg and 0.45 μg increment/decrement for butorphanol and sufentanil,respectively.Results The ED50 of butorphanol was 0.80 mg (95% CI0.74-0.87 mg),and the ED50 of sufentanil was 3.68 μg (95% CI 3.07-4.41 μg).The ED50 of butorphanol and sufentanil was 0.28 mg (95% CI 0.25-0.32 mg) and 2.82 μg (95% CI 2.52-3.16 μg),respectively,in group BS1.The ED50 of butorphanol and sufentanil was 0.38 mg (95% CI 0.33-0.43 mg) and 1.7 μg (95% CI 1.5-1.9 μg),respectively,in group BS2.The isobolographic analysis showed that the combination of butorphanol and sufentanil at 2 ∶ 1 or 1 ∶ 1 produced an additive analgesic effect.Conclusion The analgesic effect of butorphanol and sufentanil is additive when combined at the ratio of 2 ∶ 1 or 1 ∶ 1 based on the equivalent dose.